The effects of 6-amino-2-n-pentylthiobenzothiazole (APB), a new antifungal agent, on ergosterol biosynthesis in Candida albicans and Saccharomyces cerevisiae were studied, using [ 14 C]acetate incorporation. In C. albicans, the inhibition of growth was accompanied by a marked inhibition of acetate incorporation in 4-desmethylsterols, with a significant portion of the radiolabel being incorporated in 4,4-dimethylsterols, lanosterol, and 4,4-dimethylzymosterol and minor amounts being incorporated in 4-methylsterols and squalene. The data are interpreted as evidence of a block of the ergosterol biosynthesis pathway at the level of 4-demethylation of 4,4-dimethylzymosterol, with partial inhibition of lanosterol 14-demethylation and squalene epoxidation also being possible. In 6-amino-2-n-pentylthiobenzothiazole-treated S. cerevisiae, a significant amount of the radiolabel was incorporated also in 4-methylsterols, 4-methylzymosterol, and 4-methylfecosterol, indicating that in this microorganism there are different sensitivities of the two 4-demethylations and that the pathway is blocked at the level of 4-demethylation of 4-methylsterols.
Growth of the population with altered immunity, which has taken place during the last 15 years, has led to an increase in the incidence of invasive and systemic mycoses. In spite of recent advances in the development of antimycotic agents, antifungal chemotherapy remains in many cases problematic and the search for new antifungal agents continues (16) .
A promising new antifungal agent is 6-amino-2-n-pentylthiobenzothiazole (APB) (Fig. 1) . It has been shown to be active against various Candida species in vitro, to inhibit the yeastmycelium conversion in Candida albicans, and to be active in vivo, curing systemic candidosis in mice (4, 5, 12) .
The mechanism of action of APB in Saccharomyces cerevisiae was studied (11) : there was a reduction in the cellular content of ergosterol, which was accompanied by an accumulation of squalene and 4-methylated sterols, following APB treatment. These effects differed from those caused by other antifungal drugs, such as azoles, which are established ergosterol biosynthesis inhibitors. It was previously suggested (11) that APB was an inhibitor of a new target site in the ergosterol biosynthesis pathway, namely, sterol 4-demethylation.
In this paper, we report the effects of APB on growth and on ergosterol biosynthesis in a clinically important yeast-like microorganism, C. albicans, and present evidence that the antifungal agent inhibits ergosterol biosynthesis at the level of 4-demethylation. So as to better understand the mechanism of action of the compound, the effects on C. albicans are compared with those observed with S. cerevisiae.
MATERIALS AND METHODS
Antifungal agent. APB (Fig. 1) was provided by E. Sidóová, Chemical Institute, Faculty of Natural Sciences, Comenius University, Bratislava, Slovakia. Solutions of APB were freshly prepared in dimethyl sulfoxide when required.
The amount of the solvent in the culture media did not exceed 0.1% (vol/vol) and had no effect on the growth of the cultures.
Microorganisms and cultivation. C. albicans IEM 49/64 (Institute of Hygiene and Epidemiology, Prague, Czech Republic) and S. cerevisiae FL200 (ATCC 32119) were grown with rotary shaking (2.5 Hz) at 30ЊC in YEPD medium containing 1% (wt/vol) yeast extract (Serva), 2% (wt/vol) proteose peptone (Difco), and 2% glucose. Culture growth was monitored by spectrophotometry at 600 nm. Specific growth rates were calculated from log 2 A 600 versus time responses by linear regression.
Acetate incorporation. Yeast cultures at the beginning of the exponential growth phase (A 600 ϭ 0.10 to 0.15) were divided into subcultures to which were added APB solutions of various concentrations. One hour later, sodium [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] C]acetate (specific radioactivity 2 GBq/mmol; Radiochemicals Institute, Prague, Czech Republic) was added, to give a final concentration of 3.7 kBq/ml. The cultures were incubated for a further 4 h, and then the biomass was collected by centrifugation and washed with cold distilled water.
Extraction of NSL. Yeast biomass was treated with a volume of 0.1 M HCl (20 min at 91ЊC), and nonsaponifiable lipids (NSL) were extracted and saponified by adding the same volume of 25% (wt/vol) KOH in ethanol, containing 0.2% (wt/vol) pyrogallol, and incubating for 1 h at 73ЊC (7, 10, 14) . The NSL were extracted into hexane, reduced in volume under a stream of nitrogen gas, and stored at Ϫ20ЊC in the dark before analyzing within 1 week.
Analysis of NSL. Thin-layer chromatography was carried out, using 0.25-mmthick Silica Gel 60 precoated plates (Macherey-Nagel, Düren, Germany), developed twice in dichloromethane (3). Ergosterol, lanosterol, and squalene standards (all from Sigma) were analyzed on the same plate with the samples. The NSL fractions were visualized by iodine vapor, scraped off, suspended in scintillation liquid (SLS31; Spolana, Neratovice, Czech Republic), and measured in a Packard Tri-Carb 1500 scintillation counter operating in the efficiency tracing mode. Output disintegrations per minute were corrected for different molar radioactivities of individual fractions.
Gas chromatography-mass spectrometry analyses were carried out with a Hewlett-Packard HP 5971A mass-selective detector directly coupled to an HP 5890 Series II gas chromatograph equipped with an Ultra 1 (Hewlett-Packard) capillary column (internal diameter, 25 m by 0.2 mm; thickness, 0.33 m). Column temperature was programmed from 70ЊC (2 min) to 280ЊC (39 min) at 15ЊC/min. Helium at a flow rate of 1 cm 3 /min was used as the carrier gas. Samples were injected by using the splitless technique at an injector temperature of 280ЊC. The detector ion-source temperature was 170ЊC, and the electron energy was 70 eV. Mass spectra were interpreted, and the peaks were identified as described previously (11) .
For detailed analysis and identification, prior to analysis by gas chromatography-mass spectrometry, the NSL were first separated into squalene, 4,4-dimethylsterol, 4-methylsterol, and 4-desmethylsterol fractions by semipreparative normal-phase high-pressure liquid chromatography, using a Separon SGX (particle size, 7 m) silica gel column (250 by 8 mm; Tessek, Prague, Czech Republic), with dichloromethane as the eluting solvent at a flow rate of 6 ml/min, an injection volume of 200 l, and spectrophotometric detection at 235 nm.
RESULTS AND DISCUSSION
The ergosterol biosynthesis pathway is a target for the majority of the antifungal drugs which are in current use. Various enzymic reactions in this pathway are inhibited by antimycotic agents: squalene epoxidation is inhibited by allylamines, sterol 14-demethylation is inhibited by azoles, and sterol 14-reduction and ⌬
-⌬
7 -isomerization are inhibited by dimethylmorpholines. Action of these antifungal agents results in ergosterol insufficiency in sensitive fungal cells, accompanied by an accumulation of ergosterol precursors or of their unusual metabolites (2) .
An alternative target in the ergosterol biosynthesis pathway, namely, 4-demethylation, has been proposed to be inhibited by a new antifungal agent, APB (11) . To evaluate this hypothesis, in this study we have investigated the effects of the compound in C. albicans and S. cerevisiae, using [
14 C]acetate incorporation to monitor ergosterol biosynthesis.
Exponentially growing cultures of C. albicans were treated with APB at various concentrations, incubated with [ 14 C]acetate, and analyzed. The APB-treated cultures exhibited a steep growth-to-concentration response (Fig. 2) : 20 to 60 M APB caused a concentration-dependent prolongation of the lag phase, with only a slight decrease in the specific growth rates, whereas 80 and 100 M APB caused much more severe inhibition of growth. When the specific growth rates are calculated, concentrations up to 60 M APB caused up to 26% inhibition of growth, whereas 80 and 100 M resulted in Ն70% inhibition (Table 1) .
Partial inhibition of culture growth by APB was accompanied by a partial inhibition of ergosterol biosynthesis, with some radiolabel being incorporated in 4-methylated sterols and squalene and the remainder being incorporated in 4-desmethylsterols, a distribution which was similar to that of radioactivity in the control. When growth was inhibited by Ն70%, there was a marked inhibition of radiolabel incorporation in 4-desmethylsterols, with a significant portion of the radiolabel being incorporated in the 4,4-dimethylsterol fraction and minor portions being incorporated in 4-methylsterols and squalene (Table 2) .
To further identify the accumulating sterols analyzed by thinlayer chromatography, a nonlabelled 100 M APB-treated culture of C. albicans was prepared and analyzed by gas chromatography-mass spectroscopy. Individual sterols were identified on the basis of retention times and mass spectra, according to (11) and relatively quantified on the basis of total ion counts. It was found that the accumulating 4,4-dimethylsterol fraction contained 69% lanosterol and 31% 4,4-dimethylzymosterol.
On the basis of the known pathway of ergosterol biosynthesis in C. albicans (1, 9) these results suggest that in this organism, APB blocks the pathway at the level of 4-demethylation of 4,4-dimethylzymosterol (Fig. 3) . Two previously identified target sites, namely, squalene epoxidation and lanosterol 14-de- a Mean values of (specific growth rate) from three independent cultures are presented.
b ND, not determined.
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methylation, also appear to be partially inhibited by APB. This may be a consequence of side effects of APB directly influencing the responsible enzymes. Another possibility is that APB acts on some system(s) supporting all three enzymes, e.g., on the microsomal electron transport system (18), on oxygen supply, or on another target(s) with some linkage to the ergosterol biosynthesis pathway. It is also possible that the increased acetate incorporation in squalene and lanosterol is just a consequence of a block further in the pathway. This would be similar to the situation in yeast 14-demethylation mutants in which squalene also accumulated, although only a subsequent step in the biosynthetic pathway was blocked (17) . Compared with the case for C. albicans, a somewhat different response to APB treatment was observed with S. cerevisiae. In this organism, the growth rates of the cultures were decreased in a gradual, concentration-dependent manner in response to APB, retaining a true exponential character ( Fig. 2 and Table 1 ). In APB-inhibited S. cerevisiae, a significant portion of the radiolabel was incorporated in 4-methylsterols as well as in 4,4-dimethylsterols (Table 2) , and subsequent gas chromatography-mass spectrometry analysis of the fractions from a culture treated with 80 M APB showed that this fraction contained 41% 4-methylzymosterol and 59% 4-methylfecosterol. The composition of the 4,4-dimethylsterol fraction from APB-inhibited S. cerevisiae was 43% lanosterol and 57% 4,4-dimethylzymosterol. On the basis of the known ergosterol biosynthesis pathway in S. cerevisiae (8) , our results suggest that in this organism the first 4-demethylation of 4,4-dimethylzymosterol is only partially inhibited by APB and that the pathway is blocked at the level of 4-demethylation of 4-methylzymosterol and 4-methylfecosterol (Fig. 3) . This evidence also suggests that the two 4-demethylations in ergosterol biosynthesis in S. cerevisiae are nonequivalent, indicating that different enzyme systems catalyzing 4-demethylation of 4,4-dimethylsterols and 4-methylsterols, respectively, are active in S. cerevisiae. This would not be surprising, since such distinct enzyme systems have been identified in plant microsomes (15) .
We have obtained results similar to those reported here with other C. albicans and S. cerevisiae strains (data not presented), which confirm that the described effects of the antifungal agent are representative for the two species studied.
The results presented in this paper suggest that APB is an antifungal agent inhibiting ergosterol biosynthesis at the level of 4-demethylation. This unique mechanism seems particularly interesting, since sterols bearing 4-methyl groups are known to be unable to function in yeast membranes and, hence, their removal during ergosterol biosynthesis is essential (6, 13) . The importance of 4-demethylation in ergosterol biosynthesis is also underlined by the fact that no yeast mutant defective in this reaction step has yet been isolated. In view of these facts, APB may offer particular potential as a mechanism-based antimycotic agent. 
